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The external loop linking the M2 and M3 transmembrane
domains is crucial for coupling agonist binding to channel gating in
the glycine receptor chloride channel (GlyR). A substituted cysteine
accessibility scan previously showed that glycine activation
increased the surface accessibility of 6 contiguous residues (Arg271–
Lys276) toward the N-terminal end of the homomeric 1 GlyR
M2–M3 loop. In the present study we used a similar approach to
determine whether the allosteric antagonist, picrotoxin, could
impose conformational changes to this domain that cannot be
induced by varying agonist concentrations alone. Picrotoxin slowed
the reaction rate of a sulfhydryl-containing compound (MTSET)
with A272C, S273C, and L274C. Before interpreting this as a picro-
toxin-specific conformational change, it was necessary to eliminate
the possibility of steric competition between picrotoxin and
MTSET. Accordingly, we showed that picrotoxin and the structur-
ally unrelated blocker, bilobalide, were both trapped in the R271C
GlyR in the closed state and that a pointmutation to the pore-lining
Thr6 residue abolished inhibition by both compounds. We also
demonstrated that the picrotoxin dissociation rate was linearly
related to the channel open probability. These observations consti-
tute a strong case for picrotoxin binding in the pore. We thus con-
clude that the picrotoxin-specific effects on the M2–M3 loop are
mediated allosterically. This suggests that the M2–M3 loop
responds differently to the occupation of different binding sites.
The glycine receptor chloride channel (GlyR)2 mediates inhibitory
neurotransmission in the central nervous system (1, 2). Like othermem-
bers of the cysteine-loop ligand-gated ion channel (LGIC) family, func-
tional GlyRs comprise 5 subunits arranged symmetrically around a cen-
tral ion-conducting pore. Each subunit consists of a large extracellular
ligand-binding domain followed by 4 -helical transmembrane
domains, termed M1–M4 (3, 4).
It is now well established that the extramembranous loop joiningM2
and M3 is crucial for transmitting the agonist-induced conformational
change to the M2 domain activation gate (5–8). Consistent with this
role, a substituted cystine accessibility study on the1GlyR showed that
the surface accessibility of 6 contiguous cysteine-substituted residues in
this loop (Arg271 to Lys276) was increased in the open state (9). Thus, the
conformational status of the M2–M3 loop depends on the degree to
which the receptor is activated by agonist. However, it is not known
whether allosteric modulators could impose conformational changes to
this loop that cannot be induced by simply varying the agonist concen-
tration alone. This is an important question as it could reveal a hitherto
unexpected complexity in the role of this important domain. In partic-
ular, it would address the hypothesis that the M2–M3 loop conforma-
tion can be modified in different ways by different ligands.
In this study we address this question by determining whether the
closure of the channels by the allosteric inhibitor, picrotoxin (PTX),
preserves the relationship between domain conformation and fractional
peak current magnitude that is seen in its absence. If this relationship is
not preserved, we would conclude that the PTX-induced closed state is
conformationally different from the unliganded closed state.
PTX inhibits most anionic LGICs including the recombinant 
homomeric GlyR, the GABA type-A receptor (GABAAR), and the
invertebrate glutamate receptor Cl channel (GluClR). PTX is a use-de-
pendent inhibitor of GABAAR (10) andGluClR (11), but displays no use
dependence at the  homomeric GlyR (12). PTX inhibition is extremely
sensitive to mutations to residues at the 2 and 6 pore-lining positions
(11, 13–18). Although this implies that PTX binds in the pore, it is
unlikely that picrotoxin inhibition is because of classic pore block. Data
obtained using a variety of techniques including single channel kinetic
and conductance analysis (10, 19), macroscopic current kinetic analysis
(20), interactions between picrotoxin analogs (21), site-directed
mutagenesis (12, 22), and combined fluorescence labeling and electro-
physiology (23) together form a strong case that PTX allosterically
inhibits anionic LGICs. PTX may be a useful modulator for the present
investigation asmutations in theM2–M3 loop have profound effects on
its mode of action (12).
MATERIALS ANDMETHODS
Mutagenesis and Expression of Human GlyR 1 Subunit cDNAs—
Site-directed mutations were incorporated as previously described (9).
The WT and mutant GlyRs investigated in this study incorporated the
functionally silent C41A mutation (9). Plasmid constructs were tran-
siently transfected into HEK293 cells via the calcium phosphate precip-
itation method. Cells were washed 24 h later, and currents were
recorded over the next 72 h.
Patch Clamp Electrophysiology—Currents were measured using
whole cell recording at a holding potential of 40 mV using an Axo-
patch 1D amplifier (Axon Instruments, Foster City, CA), and data were
directly recorded to disk using pCLAMP 6 or 9 software (Axon Instru-
ments). Cells were perfusedwith the standard bathing solution contain-
ing (in mM): 140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, 10 glucose,
pH 7.4. Patch pipettes had tip resistances of1.5 M when filled with
the standard intracellular solution containing (in mM): 145 CsCl, 2
CaCl2, 2 MgCl2, 10 HEPES, 10 EGTA, pH 7.4. PTX and bilobalide (BB)
(both from Sigma) were stored as 10–100mM stock solutions inMe2SO
for up to 3months and dissolved into the bath solution on the day of the
experiment. Methanethiosulfonate ethyltrimethylammonium (MTSET),
from Toronto Research Chemicals (Toronto, Canada), was prepared as
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a stock solution of 10mM in distilled water andmaintained on ice for up to
3huntil used. Itwas applied to cellswithin30 sof beingdissolved into room
temperature bathing solution. The disulfide reducing agent, dithiothreitol
(DTT) was prepared daily as a 1mM solution in the standard bathing solu-
tion. Solutionswereapplied tocells via aparallel systemofgravity-fed tubes,
and solution exchange was effected with a time constant of about 100 ms.
Experiments were performed at room temperature (19–22 °C).
The effects of MTSET on glycine-gated currents were tested as fol-
lows. Prior toMTSET application, cells were bathed in 1 mMDTT for 1
min to ensure that exposed sulfhydryl groups were fully reduced. Then
the glycine dose response was measured at least 3 times over a period of
10mintoensure thatEC10andEC30glycineconcentrationscould reliably
be chosen and that the currentmagnitudewas invariant (5%) prior to the
application of MTSET. Following application of the MTSET-containing
solution, cells were washed in control solution for at least 2 min before the
current magnitudes were measured again. This was done to ensure that
cysteinemodification had taken place. Currentswere then reduced to their
original control levels by a 1-min exposure to 1–2mMDTT.
Data Analysis—Results are expressed as mean  S.E. of three or
more independent experiments. The empirical Hill equation, fitted by a
non-linear least squares algorithm (Sigmaplot 9.0, Systat Software Inc,
Richmond, CA), was used to calculate the 50% effective concentrations
for PTX inhibition (IC50) and the Hill coefficient (nH) values. Exponen-
tial fits were performed using the same non-linear least squares algo-
rithm. Statistical significance was determined by Student’s paired or
unpaired t test (as indicated) with p 0.05 representing significance.
RESULTS
PTX Interactions with the M2–M3 Loop—The peak current magni-
tudes and glycine EC50 values for all mutant GlyRs examined in this
study have previously been published (9). Because the present study
concerns the effects of PTX on M2–M3 loop conformation, it was first
FIGURE 1. PTX dose-response curves. A, exam-
ples of the effects of various PTX concentrations
onglycine currents recorded fromcells expressing
the indicatedmutant GlyR. The glycine concentra-
tion used to activate each receptor is shown in
TABLEONE.B, averagedPTXdose-response curves
from the WT GlyR, plus the R271C, A272C, and
S273CGlyRs (left panel), and theL274C, P275C, and
K276C GlyRs (right panel). The parameters of best
fit averaged from individual dose-response curves
are summarized in TABLE ONE.
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necessary to measure themean PTX IC50 and nH values for theWT and
all cysteine-substituted GlyRs. Sample recordings from cells expressing
each mutant GlyR examined in this study are shown in Fig. 1A. These
show the effects on increasing concentrations of PTX on currents acti-
vated by EC30-EC50 glycine concentrations. Averaged PTX dose
responses are displayed in Fig. 1B (separated into two panels for clarity)
and the mean IC50 and nH values are summarized in TABLE ONE,
together with the glycine concentration at which each was measured.
These results reveal two general features. First, as shown in TABLE
ONE, the nH values for all cysteine mutants were 1, which is signifi-
cantly less than the nH value for the WT GlyR of around 1.5. These
results imply that PTX inhibits the WT GlyR in a cooperative manner,
but that this cooperativity is lost when mutations are incorporated into
the N-terminal half of the M2–M3 loop. Mutagenesis also significantly
increased the PTX sensitivity of most mutants, except for A272Cwhere
there was no significant difference, and L274C where there was an
5-fold reduction in PTX sensitivity. In agreement with a previous
report (12), these results indicate that loop mutations affect the allos-
teric actions of PTX, but they provide no evidence for the direct disrup-
tion of a PTX binding site.
Our original aim was to determine the effect of PTX on the MTSET
reactivity of cysteines introduced individually to positions 271–276 in
the 1 GlyR. We previously demonstrated that the MTSET reaction
rates for all cysteine-substituted mutants are increased in the channel
open state (9). To assess the effect of PTX on cystine accessibility, we
first measured theMTSET reaction rates of all mutants at the EC10 and
EC30 glycine concentrations. (As MTSET reaction rate is proportional
to the degree of receptor activation, we expect this to increase with
increasing glycine concentration.) We then added a sufficient concen-
tration of PTX to the EC30 glycine concentration to inhibit the current
to the EC10 current magnitude. If the MTSET reaction rate depends
only on the channel open probability, then the reaction rates in the
presence of PTX EC30 glycine should be identical to its reaction rate
in the presence of EC10 glycine. However, if the respective reaction rates
are different, it may be possible to conclude that PTX promotes a con-
formational state that cannot be attained by glycine.
An example of such an experiment performed on the S273C mutant
GlyR is shown in Fig. 2A. All traces in this figure are from the same cell.
The upper left panel shows the effect of 100 M MTSET applied in the
presence of an EC10 (in this case 30 M) concentration of glycine. A
2-min wash in control solution had no effect, although the MTSET-
induced current increase was completely reversed by a 1-min exposure
to 1 mM of the reducing agent, DTT (Fig. 2A). These observations con-
firm that MTSET acted via a covalent modification of S273C. The time
course of the MTSET-induced current change was adequately fitted by
a single exponential with a time constant of 1.6 s (upper right panel). The
corresponding current changes in the presence of EC30 glycine alone or
EC30 glycine 10MPTXwere fitted by time constants of 1.1 and 3.8 s,
respectively (Fig. 2A,middle and lower panels). The same experimental
protocol was applied to 2 other cells expressing the S273Cmutant GlyR
and the averaged results are summarized in Fig. 2B. These results are
normalized to the MTSET reaction rate measured in the presence of
EC10 glycine. A paired t test (p 0.05) indicates that 10MPTX EC30
glycine caused a significant reduction in the MTSET reaction rate with
S273C relative to that caused by EC10 glycine (Fig. 2B).
We used a similar protocol to examine the effect of PTX on MTSET
reaction rates with the R271C, A272C, L274C, P275C, and K276C
mutant GlyRs. In the A272C and L274C mutant GlyRs, PTX  EC30
glycine also caused a significant reduction in the reaction rate relative to
that seen in the presence of EC10 glycine alone (Fig. 2B). However, in the
P275C GlyR, the reaction rate in PTX  EC30 glycine was not signifi-
cantly different to that obtained with EC10 glycine (Figs. 2B and 3A).
This negative result was confirmed in each of 5 cells, and the averaged
results are shown in Fig. 2B. This result is not surprising as the reaction
rate differential between the closed state and EC30 glycine-activated
TABLE ONE
PTX sensitivity of WT andmutant GlyRs
GlyR Glycine	a PTXIC50 nH n
mM M
WT 0.03 18 1 1.5 0.1 5
R271C 3 7.1 0.9b 0.77 0.07b 8
A272C 3 17 6 0.58 0.09b 4
S273C 0.04 0.68 0.04b 0.78 0.05b 3
L274C 0.25 103 26b 0.52 0.07b 4
P275C 2 5.0 1.4b 0.78 0.09b 4
K276C 3 4.9 1.6b 0.60 0.06b 4
a This shows the glycine concentration used to measure PTX dose responses.
b Significantly different fromWT value using an unpaired t test (p 0.05).
FIGURE 2. Effect of PTX on the MTSET reactivity of mutant GlyRs. A, all data in this
panel were recorded from the same cell expressing the S273C GlyR. In this and all sub-
sequent figures, the time course of glycine and MTSET application are shown by the
unfilled and filled bars, respectively.MTSETwas applied at a concentrationof 100M in all
experiments unless otherwise stated. In this cell, the glycine EC10 and EC30 concentra-
tions were 50 and 70 M, respectively. The upper and middle traces show current
responses to MTSET at EC10 and EC30 glycine concentrations, respectively, and the bot-
tom trace shows the effect of simultaneous application of MTSET, EC30 glycine, and 5M
PTX. Single exponential fits to the MTSET-induced current change are displayed in the
right panel. A control glycine application 2min after MTSET reaction indicates the effect
is irreversible. Traces in the upper,middle, and lower panels are separated by 1-min appli-
cations of 1 mM DTT. B, summary of changes in MTSET reaction rate associated with the
three experimental conditions as depicted in A. All reaction rates are normalized to the
value recorded in the presence of EC10 glycine. Data for S273C were averaged from 3
cells, and a Student’s paired t test reveals a significant difference between the EC10
glycine reaction rate and the EC30 glycine 5mM PTX reaction rate (p 0.05). Statistical
significance is denoted by the asterisk. A similar analysis was performed on all other
mutants and the mean results are displayed for A272C (n
 4 cells), L274C (n
 4 cells),
and P275C (n
 5 cells).
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state in this mutant is less than 3-fold (9), implying that the surface
exposure of P275C varies little during gating.
The effects of PTX onMTSET reactivity of R271C and K276C could
not be measured. As shown in the example in Fig. 3B, an increase in the
R271C reaction rate was observed as the glycine concentration was
increased from EC10 to EC30. Surprisingly, however, PTX abolished the
change in current that otherwise occurs upon the addition ofMTSET to
these mutants (Fig. 3B, bottom trace). A similar lack of effect was
observed in each of 4 cells expressing the R271C GlyR and in 4 cells
expressing theK276CGlyR. There are 2 likely explanations for this. One
is thatMTSET cannot reach its reaction site in the presence of PTX and
the other is that MTSET modification caused an increase in PTX sen-
sitivity, so that the enhanced PTX inhibition exactly cancelled out the
MTSET-induced current increase. If both MTSET and PTX are
removed following simultaneous exposure, the magnitude of the gly-
cine-activated current increases to the same value as seen following
exposure toMTSET in the absence of PTX (Fig. 3B, compare center and
bottom traces). This indicates thatMTSETmodification has taken place
and that MTSET modification must therefore cause an increased PTX
sensitivity in the R271CGlyR. This was tested directly bymeasuring the
degree of inhibition induced by 10 M PTX on currents activated by 3
mMglycine both before and afterMTSETmodification. BeforeMTSET,
PTX inhibited currents to 51  3% of control, but in the same 4 cells
after MTSET modification, it inhibited currents to 28 7% of control.
This difference was statistically significant (p  0.05) using a paired t
test. A similar experiment performed on the K276C GlyR yielded a
similar result. A 10 mM PTX concentration inhibited currents activated
by 5mMglycine to a level of 35 6% beforeMTSETmodification and to
10  3% after modification. Again, this difference was statistically sig-
nificant using a paired t test (n
 4 cells, p 0.05).Hence, it is concluded
that the lack of current change upon simultaneous application of
MTSET  PTX can be attributed to an MTSET-induced increase in
PTX sensitivity.
The conclusion thus far is that PTX reduces the reaction rate of
MTSET with A272C, S273C, and L274C. There are 3 possible ways by
which this could be achieved. The first is that PTX and MTSET may
form a complex in free solution. This possibility was eliminated by
showing that the PTX IC50 for the WT GlyR was not significantly
affected by the presence of 1 mM MTSET (not shown). The second
possibility is that PTX changes the conformation of this domain via an
allosteric action. The third is that PTX binds to either this domain or a
nearby domain and sterically interferes with the MTSET reaction. To
discriminate between these two possibilities, it is essential to identify the
location of the PTX binding site.
PTX Interactions with the Pore—During the course of the above
experiments, we noticed that recovery from PTX inhibition required
the R271C GlyR to be activated by glycine. This effect is characterized
formally in Fig. 4. Fig. 4A shows a control in which 2 applications of an
EC50 (3 mM) concentration of glycine spaced60 s apart are similar in
magnitude. Fig. 4B shows the slow recovery that follows the complete
inhibition of this current by a saturating (300 M) concentration of
PTX. If both glycine and PTX are simultaneously removed when the
current is inhibited, it is apparent that recovery from PTX inhibition
commences only when glycine is applied 60 s later (Fig. 4C). Thus, PTX
is “trapped” in the absence of glycine. As shown in the inset, overlay of
the PTX inhibition recovery phases recorded in Fig. 4, B and C, reveal
identical time courses of recovery. When PTX is applied in the closed
state (Fig. 4D), a subsequent application of glycine indicates that PTX
cannot efficiently access its inhibitory site. Identical experiments to
these were performed in each of 5 cells, and the results are summarized
in Fig. 4, E and F. Fig. 4E shows the percentage of original current that
was observed 65 s after the initial glycine current was terminated for the
four experimental conditions depicted in Fig. 4, A–D. The 0- and 65-s
time points are indicated by the vertical dashed line. Fig. 3E reveals that
the only condition that causes a significant decrease in glycine current at
the 65-s time point is when PTX is trapped for 60 s in the closed state.
Fig. 3F measures the ratio of currents from 5 cells measured at 1-s
intervals during the recovery from PTX inhibition following trap rela-
tive to the current recorded at the same recovery time point without
trap. As there is no substantial deviation from 1 at any point, we con-
clude that the recovery rate following the 60-s trap is no different from
its recovery rate without trap. We also observed PTX trap in the
MTSET-modified R271C GlyR and the K276C GlyR (n 
 3 for each,
data not shown), but not in any other mutant GlyR tested in this study.
PTX has long been hypothesized to bind in the GlyR pore (24). How-
ever, as discussed below, the evidence supporting this is not overwhelm-
FIGURE 3. Sample results for P275C and R271C using the protocol as described in
the legend to Fig. 2A. A, all data in this panel were recorded from a cell expressing the
P275C GlyR. In this cell, glycine was applied at 1 and 3 mM (corresponding to EC10 and
EC30), and PTX was applied at 10M. Note the apparent lack of effect of glycine concen-
tration and PTX on MTSET reaction rates. Data averaged from 5 cells confirms this (Fig.
2B). B, all data in this panel were recorded from a cell expressing the R271C GlyR. The
experimental protocol in the upper 2 panelswas the same as in Fig. 2A. In this cell, glycine
was applied at 1 and 3 mM, and PTX was applied at 10 M. In the bottom panel, control
glycine applications before and after MTSET reveal that MTSET did induce a current
increase that became apparent only after PTX washout.
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ing. Nevertheless, on the basis of the PTX trap observation, we retained
the hypothesis that PTX binds in the pore, and we designed several
experiments to test this.
The first of these is summarized in Fig. 5. We reasoned that if PTX
can escape from the R271C GlyR pore in the open state only, then its
recovery rate should be proportional to the channel open probability.
To test this, currents activated by 0.3, 1, 3, 10, and 20 mM glycine were
completely inhibited by 300 M PTX and the time course of the recov-
ery current was recorded. An example of one such experiment is dis-
played in Fig. 5A. The number of exponential terms needed to ade-
quately fit the recovery phase varied from cell to cell because of the
variable presence of a small rapidly recovering current component. As a
maximum of around 10% of the current recovers by this fast pathway, it
is ignored for the purpose of this analysis and a single exponential curve
was fit only to the remaining slow recovery phase. The time constants
averaged from 4 cells reveal a consistent relationship between recovery
rate and glycine concentration (Fig. 5B). The same data are plotted in a
different way in Fig. 5C. In this analysis, we made use of the fact that 20
mM glycine is saturating at the R271C GlyR (9). We then expressed the
current magnitudes activated by 1, 3, and 10 mM as a fraction of the
saturating current in each cell and plotted this against the inverse of the
dissociation time constant (i.e. dissociation rate). The pooled results,
displayed in Fig. 5C, were well fitted by a linear regression with a regres-
sion coefficient of 0.79, implying a linear relation between the PTX
unbinding rate and channel open probability. Such a relationship is
expected for a molecule than can escape from its site only in the open
state. However, this linearity is disrupted at open probabilities less than
around 0.2, implying that PTX cannot easily escape during the fast
opening events typical of weakly liganded GlyRs (25).
We then reasoned that if PTX is trapped in the pore of the R271C
GlyR, then other putative pore-blocking substances with unrelated
structures should also be trapped. There are two families of molecules
that block GlyRs: cyanotriphenylborate (26) and several structurally
related extracts fromGinkgo biloba leaves (27, 28). In this study, we used
the sesquiterpene trilactone Ginkgo component, BB. Sample responses
to increasing concentrations of BB on WT GlyR currents are shown in
Fig. 6A (left panel), and the averaged dose response pooled from 4 cells
is shown in Fig. 6A (right panel). The mean BB IC50 was 19.6 1.6 M
and the nH value was 0.58  0.06 (both n 
 4). As the G. biloba deriv-
atives have only been tested on native GlyRs with unknown subunit
compositions, it was first necessary to confirm that BB inhibited the
recombinantly expressedGlyR homomer in a use-dependentmanner.
This was performed as indicated in Fig. 6B. The upper and lower left
panels show the effects of 10MBB applied in the closed and open states,
respectively. As seen in the lower panel, glycine-induced current activa-
tion following BB removal is slow as a result of the slow dissociation of
FIGURE4.PTX trap in theR271CGlyR.A, all data inA–Dwere from the samecell. Glycine
was applied throughout at 3 mM and PTX at 300 M. Panel A shows 2 control glycine
applications spaced 60 s apart. B, glycine was applied as shown by the unfilled bar, and
PTXwasappliedas indicatedby the filledbar. Note the slow recovery fromPTX inhibition.
C, similar experiment to B except that glycine and PTX were simultaneously removed
once PTX inhibition reached steady-state. Glycine was reapplied 60 s later revealing
the PTX trap. The inset shows the overlaid recovery current time courses from panels B
and C. D, PTX applied in the closed state does not cause significant trap. E, the mean
current amplitude at the 65-s time point is expressed as a percentage of the control
current magnitude for the four experimental conditions depicted in panels A–D. The 0-
and 65-s time points are shown by the vertical dashed lines. All experiments were aver-
aged from5 cells, and only experiment B caused a significant (p 0.05) current decrease
at 65 s. This measure indicates that the results summarized in A–Dwere typical of those
obtained in all cells tested. F, the magnitude of the current at 1-s intervals during recov-
ery from trap is expressedas a ratio of the current at the corresponding timepoint during
recoverywithout trap. All points are averaged from5 cells. Theplot reveals no significant
difference in their respective recovery time courses.
FIGURE 5.Glycine concentration-dependence of the PTX inhibition recovery rate in
the R271CGlyR. A, all data were from the same cell. Currents activated by the indicated
glycine concentrationswere completely inhibited by 300MPTX, and the time course of
recovery was compared at the same glycine concentrations. B, the current recovery
phasewas fittedwith a single exponential. Results pooled from4cells reveal a consistent
relationship between recovery time constant () and glycine concentration. C, for each
recovery curve, the recovery rate (
 1/) was plotted against the current at which it was
recorded expressed as a fraction of themaximum saturating current. (Saturation occurs
at 20mMglycine in thismutant.) The points from left to right in this plot represent pooled
data recorded at 1, 3, 10, and 20mMglycine, respectively. Linear regression analysis of all
individual data points (not of the averaged data as plotted here) reveals a regression
coefficient of 0.79.
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BB. If BB accesses its site equally well in the closed state, the rate at
which glycine activates the channels after a closed state BB application
should be slowed to a similar extent. To facilitate comparison of glycine-
activation rates, the activation segments under each experimental con-
dition (as indicated by numbers 1, 2, and 3) were normalized, superim-
posed, and expanded in Fig. 6B, upper right panel. Single exponentials
were fit to these curves, and the time constants averaged from 4 cells are
averaged in Fig. 6B, lower right panel. This result demonstrates that BB
accesses its binding site in the open state but not the closed state. In
contrast, the same experiment performed using PTX demonstrated
rapid access to its site in the closed state (12). Thus, BB is a use-depend-
ent inhibitor of recombinant  homomeric GlyRs.
We next sought to determinewhether the effects of PTX andBBwere
mediated by common molecular determinants. The T6F mutation has
previously been shown to drastically reduce the PTX inhibitory potency
(18, 29). Sample responses of WT and T6F mutant GlyR currents to
high concentrations of PTX and BB are shown in Fig. 6C. We found in
each of 4 cells that 300 M BB had no significant inhibitory effect on
currents activated by an EC50 concentration (5 M) of glycine in the
T6F mutant GlyR. Full BB dose responses were not measured in the
T6F GlyR because of its low sensitivity and the limited quantity of the
compound. Nevertheless, these results demonstrate amarked similarity
in the mechanisms of action of PTX and BB.
The final test was to determine whether BB is trapped in the closed
state of the R271CGlyR. The results of this experiment are summarized
in Fig. 7. As with PTX inhibition, recovery from BB inhibition was slow
(Fig. 7A), and the 60-s delay in the addition of glycine indeed demon-
strated that BB is trapped in the pore (Fig. 7B). Note, however, that the
delayed addition of glycine was associated with a small step jump in
current that is not present in the corresponding trace in Fig. 7A. This
effect was observed in all 3 cells in which it was investigated and indi-
cates that BB can escape slowly from its site in the closed state.However,
as shown in Fig. 7C, BB cannot efficiently reach its inhibitory site in the
closed state. To average recovery currents from multiple cells, we first
superimposed the recovery currents recorded with and without trap.
This is shown in Fig. 7D, upper panel, where currents are aligned
according to the time that glycine-induced recoverywas initiated (aster-
isk). This clearly displays the step and the subsequent offset it induces in
the recovery phase. To compensate for this offset, the curves were
moved laterally to each other until they overlapped maximally (Fig. 7D,
lower panel). The ratio of these currents at 1-s intervals during recovery
was then calculated, with the average from 3 cells displayed in Fig. 7E.
This indicates that apart from the small step current because of slow BB
escape, a period of trap does not affect the recovery rate from BB-me-
diated inhibition.
FIGURE 6. BB effects on the WT and T6F GlyRs. A, effects of the indicated concentra-
tions of BB on currents activated by 30 M glycine in cell expressing WT GlyRs. The right
panel shows themeanBBdose response averaged from4cells. Theparameters of best fit
averaged from individual dose responses are given in the text. B, use-dependence of BB
inhibition. The upper left panel shows a 15-s pre-exposure to 10M BB followed immedi-
ately by 200 M application of glycine. The lower left panel, from the same cell, shows a
control where BB is applied in the open state. The upper right panel shows the expanded,
normalized glycine-induced activation phases corresponding to points 1, 2, and 3 in the
left panel. Curve 3 reveals a slower glycine activation rate caused by the slow rate of BB
dissociation. Activation time constants averaged from 4 cells are displayed in the lower
right panel. They show the time constants of glycine-induced activation following cell
exposure to control solution (left column), BB alone (center column), or BBglycine (right
column). BB significantly (p  0.01, paired t test) inhibited the glycine activation rate
when applied in the open state. C, currents activated by 30Mglycine in theWTGlyR are
completely inhibited by 100M PTX (left panel), whereas those activated by 5Mglycine
in the T6FGlyR are little affectedby 300MPTX (center panel). PTXdose responses in the
WT and T6F GlyRs have been quantitated as described in Ref. 18. The right panel shows
complete lack of inhibition by 300 M BB in the T6F GlyR. This trace is representative of
those recorded from 4 cells under the same conditions.
FIGURE 7.BB trap in the R271CGlyR.All data inA–Dwere all from the same cell and the
experiments in A–C were performed exactly as described in the legend to Fig. 4, B–D.
Glycine was applied throughout at 3 mM and BB at 100 M. D, superimposed initial
current recovery phases from A and B. Traces are aligned according to the time (asterisk)
that recoverywas initiated. E, as forD, except tracesweremoved laterally relative to each
other until maximum overlap was achieved. Current magnitudes at 1-s intervals were
then ratioed, and the results pooled from 3 cells are averaged in panel E.
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DISCUSSION
A Binding Site for PTX in the Pore?—PTX significantly slowed the
MTSET reaction rate with the A272C, S273C, and L274CGlyRs. Before
interpreting this as a PTX-induced conformational change, we must
first eliminate the possibility that the effect was because of steric com-
petition between PTX andMTSET. Hence, this discussion first consid-
ers the location of the PTX binding site.
PTX has long been thought to bind in the GlyR pore (24, 30). The
main evidence in favor of this is that mutations at the 6 pore-lining
position can either abolish PTX sensitivity in the PTX-sensitive 1
GlyR, or drastically enhance PTX sensitivity in the PTX-insensitive1
GlyR (18). The main evidence against a pore binding site hypothesis is
that PTX inhibition of the GlyR is not use-dependent. That is, PTX
accesses its inhibitory site efficiently in the closed state. Indeed, its
inhibitory potency is stronger at low, weakly activating glycine concen-
trations than at saturating glycine concentrations (12). These charac-
teristics are the opposite of those usually associated withmolecules that
bind deep in a pore. On the other hand, however, PTX inhibition is
use-dependent in the structurally relatedGABAAR andGluClRs (10, 11,
17, 22). Furthermore,mutagenesis of a divergent Ser15 residue in the1
GlyR pore-lining domain back toward the corresponding residues in the
GABAAR  subunit or GluClR  subunit (via the S15N and S15Q
mutations, respectively) converts PTX into a use-dependent inhibitor of
the GlyR (22). Although broadly consistent with a pore binding site for
PTX, the above evidence does not constitute a conclusive case for PTX
binding in the pore.
We demonstrate here that the R271C GlyR must be opened for PTX
to access or leave its binding site. The dissociation rate of PTX is linearly
proportional to the open probability over the range 20–100% of its
maximum value, but is substantially reduced at lower open probabilities
(Fig. 5C). These properties are expected if PTXbinds in the pore. Similar
blocker trap behavior has been observed in a variety of cation-selective
channels (31–34), although such phenomena have rarely been
described in proteins that do not possess a pore or deep crevice. The
present study also shows that mutation of the Thr6 pore-lining residue
abolishes sensitivity to both PTX and the structurally unrelated pore
blocker, BB. The fact that a single molecular determinant is crucial for
the efficacy of both compounds implies that they share a commonmode
or site of action. Indeed, Thr6 has already been proposed as a PTX
contact site, and a molecular modeling study indicates that PTX can
plausibly bind in this location (30). Furthermore, by showing that BB is
trapped by the R271C GlyR, we demonstrate that the trap effect does
not discriminate on the basis of molecular structure. This is consistent
with both molecules binding in the pore, but would be difficult to rec-
oncile with them binding to separate sites in an extramembranous part
of the protein. Finally, we have previously shown that T6C is function-
ally modified by MTSET in the open state only (18). This provides
independent evidence for a narrow pore constriction external to T6C
in the closed state. Together, these lines of evidence constitute a strong,
but not definitive, case for PTX binding in the pore of the R271C GlyR.
Our experiments donot directly addresswhyBB inhibition of theWT
GlyR is use-dependent, whereas PTX inhibition is not.We propose that
PTX efficiently accesses its site in the closed state (12) and allosterically
inhibits the GlyR by stabilizing a “closed pore ” conformation. BB may
also have efficient access to the 6 depth in the closed state, although we
propose it requires the channel to be opened for it to bind.
Why is PTX trapped in the pore of the R271C GlyR but not the WT
GlyR? The recent structural model of theTorpedomarmorata nicotinic
acetylcholine receptor transmembrane domains shows a band of hydro-
phobic residues around the middle of the M2 domain extending from
Leu9 to Val13 (8, 35). These residues are linked to the adjacent residues
on neighboring subunits by hydrophobic bonds, and thus form a central
pore constriction that holds the channel closed. Note that this constric-
tion is not necessarily the gate that controls ion flow. Evidence from
substituted cysteine accessibility studies implies that the ion gate lies in
the 2 to 2 region in the nicotinic acetylcholine receptor and
GABAAR (36–38), although it may be centrally located in the 5-hy-
droxytryptamine type 3-gated cation channel (39, 40). We propose that
the centrally located gate does not form a substantial barrier to PTX
access in the WT GlyR in the closed state. However, PTX is converted
into a use-dependent inhibitor of the GlyR by mutations to Ser15 (22)
and to R271C and K276C in the M2–M3 loop (present study). We
propose that these mutations disrupt M2 structure, leading to an even
smaller constriction at the pore midpoint. Thus, the pore must be
opened to permit the passage of large molecules like PTX. The idea that
changes in conformation of the M2–M3 loop lead to a conformational
change at the poremidpoint is a common feature of allmodels proposed
so far to explain LGIC activation (3, 41–44).
A PTX-specific Conformation Change—By binding in the pore, PTX
cannot sterically hinder MTSET from reacting with M2–M3 loop cys-
teines. We therefore conclude that PTX changes the MTSET reaction
rate by changing the intrinsic reactivity rates of the introduced cys-
teines. This study has shown that a given relative peak current magni-
tude (or EC value) is associated with a fixed cysteine reaction rate for
each mutant GlyR. Because PTX changes the relationship between EC
and cysteine reactivity, we conclude that it alters the M2–M3 loop
structure in a way that cannot be achieved by glycine.
This conclusion has important implications for our understanding of
LGIC activation mechanisms. Our current understanding is that ago-
nist binding causes a conformational change in the extracellular ligand-
binding domain and this is transmitted to the channel gate via confor-
mational changes in the M2–M3 loop (2, 3, 43, 44). Because
allosterically acting modulators also cause global changes in receptor
conformation, it is expected that these should also alter M2–M3 loop
conformation. However, until now there has been no evidence to sug-
gest that allosteric modulators could act in any other way than by sta-
bilizing theM2–M3 loop in either the glycine-liganded open conforma-
tion or the glycine-free closed conformation.
Thus, the crucial insight of this study is that PTX can alter the con-
formation of the GlyRM2–M3 loop in a way that cannot be achieved by
simply varying the glycine concentration alone. This result reveals a
hitherto unexpected complexity in the role of the M2–M3 loop. Our
results also validate the R271CGlyR as a tool for establishingwhether or
not molecules bind in the pore.
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